Phosphorylation of the RNA Polymerase II Carboxyl-Terminal Domain by CDK9 Is Directly Responsible for Human Immunodeficiency Virus Type 1 Tat-Activated Transcriptional Elongation

REFERENCES

• Akoulitchev, S., S. Chuikov, and D. Reinberg. 2000. TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature 407: 102–106.
   PubMed Web of Science ®Google Scholar
• Akoulitchev, S., T. P. Mäkelä, R. A. Weinberg, and D. Reinberg. 1995. Requirement for TFIIH kinase activity in transcription by RNA polymerase II. Nature 377: 557–560.
   PubMedGoogle Scholar
• Awrey, D. E., R. G. Weilbaecher, S. A. Hemming, S. M. Orlicky, C. M. Kane, and A. M. Edwards. 1997. Transcription elongation through DNA arrest sites: a multistep process involving both RNA polymerase II subunit RPB9 and TFIIS. J. Biol. Chem. 272: 14747–14754.
   PubMed Web of Science ®Google Scholar
• Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen. 1998. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17: 7056–7065.
   PubMed Web of Science ®Google Scholar
• Bienkiewicz, E. A., A.-Y. M. Woody, and R. W. Woody. 2000. Conformation of the RNA polymerase II C-terminal domain: circular dichroism of long and short fragments. J. Mol. Biol. 297: 119–133.
   PubMedGoogle Scholar
• Bourgeois, C. F., Y. K. Kim, M. J. Churcher, M. J. West, and J. Karn. 2002. Spt-5 cooperates with Tat by preventing premature RNA release at terminator sequences. Mol. Cell. Biol. 22: 1079–1093.
   PubMed Web of Science ®Google Scholar
• Chao, S.-H., K. Fujinaga, J. E. Marion, R. Taube, E. A. Sausville, A. M. Senderowicz, B. M. Peterlin, and D. H. Price. 2000. Flavopiridol inhibits p-TEFb and blocks HIV-1 replication. J. Biol. Chem. 275: 28345–28348.
   PubMed Web of Science ®Google Scholar
• Chen, D., Y. Fong, and Q. Zhou. 1999. Specific interaction of Tat with the human but not rodent pTEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proc. Natl. Acad. Sci. USA 96: 2728–2733.
   PubMed Web of Science ®Google Scholar
• Chen, D., and Q. Zhou. 1999. Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase. Mol. Cell. Biol. 19: 2863–2871.
   PubMed Web of Science ®Google Scholar
• Cho, H., T.-K. Kim, H. Mancebo, W. S. Lane, O. Flores, and D. Reinberg. 1999. A protein phosphatase functions to recycle RNA polymerase II. Genes Dev. 13: 1540–1552.
   PubMed Web of Science ®Google Scholar
• Christie, K. R., D. E. Awrey, A. M. Edwards, and C. M. Kane. 1994. Purified yeast RNA polymerase II reads through intrinsic blocks to elongation in response to the yeast TFIIS analogue, p37. J. Biol. Chem. 269: 936–943.
   PubMedGoogle Scholar
• Churcher, M. J., A. D. Lowe, M. J. Gait, and J. Karn. 1995. The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription. Proc. Natl. Acad. Sci. USA 92: 2408–2412.
   PubMedGoogle Scholar
• Cramer, P., D. A. Bushnell, and R. D. Kornberg. 2001. Structural basis of transcription: RNA polymerase II at 2.8 angstrom resolution. Science 292: 1863–1867.
   PubMed Web of Science ®Google Scholar
• Cujec, T. P., H. Okamoto, K. Fujinaga, J. Meyer, H. Chamberlin, D. O. Morgan, and B. M. Peterlin. 1997. The HIV trans-activator Tat binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11: 2645–2657.
   PubMed Web of Science ®Google Scholar
• Douziech, M., D. Forget, J. Greenblatt, and B. Coulombe. 1999. Topological localization of the carboxyl-terminal domain of RNA polymerase II in the initiation complex. J. Biol. Chem. 274: 19868–19873.
   PubMedGoogle Scholar
• Feinberg, M. B., D. Baltimore, and A. D. Frankel. 1991. The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation. Proc. Natl. Acad. Sci. USA 88: 4045–4049.
   PubMed Web of Science ®Google Scholar
• Fong, N., and D. L. Bentley. 2001. Capping, splicing, and 3′ processing are independently stimulated by RNA polymerase II: different functions for different segments of the CTD. Genes Dev. 15: 1783–1795.
   PubMed Web of Science ®Google Scholar
• Fong, Y. W., and Q. Zhou. 2000. Relief of two built-in autoinhibitory mechanisms in p-TEFb is required for the assembly of a multicomponent transcription elongation complex at the HIV-1 promoter. Mol. Cell. Biol. 20: 5897–5907.
   PubMed Web of Science ®Google Scholar
• Fujinaga, K., R. Taube, J. Wimmer, T. P. Cujec, and B. M. Peterlin. 1999. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl. Acad. Sci. USA 96: 1285–1290.
   PubMed Web of Science ®Google Scholar
• Garber, M. E., T. P. Mayall, E. M. Suess, J. Meisenhelder, N. E. Thompson, and K. A. Jones. 2000. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 Tat-P-TEFb complex to TAR RNA. Mol. Cell. Biol. 20: 6958–6969.
   PubMed Web of Science ®Google Scholar
• Garber, M. E., P. Wei, and K. A. Jones. 1998. HIV-1 Tat interacts with cyclin T1 to direct P-TEFb CTD kinase complex to TAR RNA. Cold Spring Harbor Symp. Quant. Biol. 63: 371–380.
   PubMedGoogle Scholar
• Garber, M. E., P. Wei, V. N. Kewel-Ramani, T. P. Mayall, C. H. Herrmann, A. P. Rice, D. R. Littman, and K. A. Jones. 1998. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12: 3512–3527.
   PubMed Web of Science ®Google Scholar
• Gnatt, A. L., P. Cramer, J. Fu, D. A. Bushnell, and R. D. Kornberg. 2001. Structural basis of transcription: an RNA polymerase II elongation complex at 3.3 Å resolution. Science 292: 1876–1882.
   PubMed Web of Science ®Google Scholar
• Gold, M. O., J.-P. Tassan, E. A. Nigg, A. P. Rice, and C. H. Herrmann. 1996. Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8. Nucleic Acids Res. 24: 3771–3777.
   PubMed Web of Science ®Google Scholar
• Graeble, M. A., M. J. Churcher, A. D. Lowe, M. J. Gait, and J. Karn. 1993. Human immunodeficiency virus type 1 trans-activator protein Tat, stimulates transcriptional read-through of distal terminator sequences in vitro. Proc. Natl. Acad. Sci. USA 90: 6184–6188.
   PubMedGoogle Scholar
• Harding, M. M., G. Y. Krippner, C. J. Shelton, A. Rodger, K. J. Sanders, J. P. Mackay, and A. S. Prakash. 1997. DNA-binding studies of XSPTSPSZ, derivatives of the intercalating heptad repeat of RNA polymerase II. Biopolymers 42: 387–398.
   PubMedGoogle Scholar
• Herrmann, C. H., and A. P. Rice. 1995. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69: 1612–1620.
   PubMed Web of Science ®Google Scholar
• Hirose, Y., and J. L. Manley. 2000. RNA polymerase II and the integration of nuclear events. Genes Dev. 14: 1415–1429.
   PubMed Web of Science ®Google Scholar
• Isel, C., and J. Karn. 1999. Direct evidence that HIV-1 Tat activates the Tat-associated kinase (TAK) during transcriptional elongation. J. Mol. Biol. 290: 929–941.
   PubMed Web of Science ®Google Scholar
• Ivanov, D., Y. T. Kwak, J. Guo, and R. B. Gaynor. 2000. Domains in the SPT5 protein that modulate its transcriptional regulatory properties. Mol. Cell. Biol. 20: 2970–2983.
   PubMed Web of Science ®Google Scholar
• Ivanov, D., Y. T. Kwak, E. Nee, J. Guo, L. F. Garcia-Martinez, and R. B. Gaynor. 1999. Cyclin T domains involved in complex formation with Tat and TAR RNA are critical for Tat-activation. J. Mol. Biol. 288: 41–56.
   PubMedGoogle Scholar
• Kao, S.-Y., A. F. Calman, P. A. Luciw, and B. M. Peterlin. 1987. Anti-termination of transcription within the long terminal repeat of HIV-1 by Tat gene product. Nature 330: 489–493.
   PubMed Web of Science ®Google Scholar
• Karn, J. 1999. Tackling Tat. J. Mol. Biol. 293: 235–254.
   PubMed Web of Science ®Google Scholar
• Keen, N. J., M. J. Churcher, and J. Karn. 1997. Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex. EMBO J. 16: 5260–5272.
   PubMedGoogle Scholar
• Kerppola, T. K., and C. M. Kane. 1990. Analysis of signals for transcription termination by purified RNA polymerase II. Biochemistry 29: 269–278.
   PubMedGoogle Scholar
• Kim, J. B., and P. A. Sharp. 2001. Positive transcription elongation factor b phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase. J. Biol. Chem. 276: 12317–12323.
   PubMed Web of Science ®Google Scholar
• Komarnitsky, P., E.-J. Cho, and S. Buratowski. 2000. Different phosphorylated forms of RNA polymerase II, and associated mRNA processing factors during transcription. Genes Dev. 14: 2452–2460.
   PubMed Web of Science ®Google Scholar
• Kulish, D., and K. Struhl. 2001. TFIIS enhances transcriptional elongation through an artificial arrest site in vivo. Mol. Cell. Biol. 21: 4162–4168.
   PubMedGoogle Scholar
• Kwak, Y. T., D. Ivanov, J. Guo, E. Nee, and R. B. Gaynor. 1999. Role of the human and murine cyclin T proteins in regulating HIV-1 Tat-activation. J. Mol. Biol. 288: 57–69.
   PubMedGoogle Scholar
• Larochelle, S., J. Chen, R. Knights, J. Pandur, P. Morcillo, H. Erdjument-Bromage, P. Tempst, B. Suter, and R. P. Fisher. 2001. T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT 1 complex in vivo and regulates its CTD kinase activity. EMBO J. 20: 3749–3759.
   PubMed Web of Science ®Google Scholar
• Mancebo, H. S. Y., G. Lee, J. Flygare, J. Tomassini, P. Luu, Y. Zhu, J. Peng, C. Blau, D. Hazuda, D. Price, and O. Flores. 1997. p-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11: 2633–2644.
   PubMed Web of Science ®Google Scholar
• Marshall, N. F., G. K. Dahmus, and M. E. Dahmus. 1998. Regulation of carboxyl-terminal domain phosphatase by HIV-1 Tat protein. J. Biol. Chem. 273: 31726–31730.
   PubMedGoogle Scholar
• Marshall, N. F., and M. E. Dahmus. 2000. C-terminal domain phosphatase sensitivity of RNA polymerase II in early elongation complexes on the HIV-1 and adenovirus 2 major late templates. J. Biol. Chem. 275: 32430–32437.
   PubMedGoogle Scholar
• Morgan, D. O. 1995. Principles of CDK regulation. Nature 374: 131–134.
   PubMed Web of Science ®Google Scholar
• Nguyen, V. T., T. Kiss, A. A. Michels, and O. Bensaude. 2001. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 414: 322–325.
   PubMed Web of Science ®Google Scholar
• Parada, C. A., and R. G. Roeder. 1996. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 384: 375–378.
   PubMed Web of Science ®Google Scholar
• Parada, C. A., J.-B. Yoon, and R. G. Roeder. 1995. A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro. J. Biol. Chem. 270: 2274–2283.
   PubMed Web of Science ®Google Scholar
• Patturajan, M., N. K. Conrad, D. B. Bregman, and J. L. Corden. 1999. Yeast carboxyl-terminal domain kinase I positively and negatively regulates RNA polymerase II carboxyl-terminal domain phosphorylation. J. Biol. Chem. 274: 27823–27828.
   PubMedGoogle Scholar
• Pavletich, N. P. 1999. Mechanisms of cyclin-dependent kinase regulation: structures of cdks, their cyclin activators, and Cip and INK4 inhibitors. J. Mol. Biol. 287: 821–828.
   PubMed Web of Science ®Google Scholar
• Ping, Y.-H., and T. M. Rana. 1999. Tat-associated kinase (P-TEF-b): a component of transcription preinitiation and elongation complexes. J. Biol. Chem. 274: 7399–7404.
   PubMed Web of Science ®Google Scholar
• Ping, Y. H., and T. M. Rana. 2001. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. J. Biol. Chem. 276: 12951–12958.
   PubMed Web of Science ®Google Scholar
• Price, D. H. 2000. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20: 2629–2634.
   PubMed Web of Science ®Google Scholar
• Ramanathan, Y., S. M. Rajpara, S. M. Reza, E. Lees, S. Shuman, M. B. Mathews, and T. Pe'ery. 2001. Three RNA polymerase II CTD kinases display distinct substrate preferences. J. Biol. Chem. 276: 10913–10920.
   PubMed Web of Science ®Google Scholar
• Renner, D. B., Y. Yamaguchi, T. Wada, H. Handa, and D. H. Price. 2001. A highly purified RNA polymerase II elongation control system. J. Biol. Chem. 276: 42601–42609.
   PubMed Web of Science ®Google Scholar
• Riedl, T., and J.-M. Egly. 2000. Phosphorylation in transcription: the CTD and more. Gene Express. 9: 3–13.
   PubMedGoogle Scholar
• Schroeder, S. C., B. Schwer, S. Shuman, and D. Bentley. 2000. Dynamic assocation of capping enzymes with transcribing RNA polymerase II. Genes Dev. 14: 2435–2440.
   PubMed Web of Science ®Google Scholar
• Siva-Raman, L., D. Reines, and C. M. Kane. 1990. Purified elongation factor SII is sufficient to promote read-through by purified RNA polymerase II at specific termination sites in the human histone H3.3 gene. J. Biol. Chem. 265: 14554–14560.
   PubMedGoogle Scholar
• Suzuki, M. 1990. The heptad repeat in the largest subunit of RNA polymerase II binds by intercalating into DNA. Nature 344: 562–565.
   PubMedGoogle Scholar
• Taube, R., K. Fujinaga, D. Irwin, J. Wimmer, M. Geyer, and B. M. Peterlin. 2000. Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1. J. Virol. 74: 892–898.
   PubMedGoogle Scholar
• Taube, R., K. Fujinaga, J. Wimmer, M. Barboric, and B. M. Peterlin. 1999. Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology 264: 245–253.
   PubMed Web of Science ®Google Scholar
• Wada, T., G. Orphanides, J. Hasegawa, D.-K. Kim, D. Shima, Y. Yamaguchi, A. Fukada, K. Hisatake, O. Sangtaek, D. Reinberg, and H. Handa. 2000. FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between p-TEFb and TFIIH. Mol. Cell 5: 1067–1072.
   PubMed Web of Science ®Google Scholar
• Wada, T., T. Takagai, Y. Yamaguchi, D. Watanabe, and H. Handa. 1998. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J. 17: 7395–7403.
   PubMed Web of Science ®Google Scholar
• Wada, T., T. Takagi, Y. Yamaguchi, A. Ferdous, T. Imai, S. Hirose, S. Sugimoto, K. Yano, G. A. Hartzog, F. Winston, S. Buratowski, and H. Handa. 1998. DSIF, a novel transcription elongation factor that regulates RNA polymerse II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12: 343–356.
   PubMed Web of Science ®Google Scholar
• Wang, G., G. T. Cantin, J. L. Stevens, and A. J. Berk. 2001. Characterization of mediator complexes from HeLa cell nuclear extract. Mol. Cell. Biol. 21: 4604–4613.
   PubMed Web of Science ®Google Scholar
• Wei, P., M. E. Garber, S.-M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel cdk9-associated c-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop specific binding to TAR RNA. Cell 92: 451–462.
   PubMed Web of Science ®Google Scholar
• Wu-Baer, F., W. S. Lane, and R. B. Gaynor. 1998. Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation. J. Mol. Biol. 277: 179–197.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, Y., T. Takagi, T. Wada, K. Yano, A. Furuya, S. Sugimoto, J. Hasegawa, and H. Handa. 1999. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97: 41–51.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, Y., T. Wada, D. Watanabe, T. Takagi, J. Hasegawa, and H. Handa. 1999. Structure and function of the human transcription elongation factor DSIF. J. Biol. Chem. 274: 8085–8092.
   PubMed Web of Science ®Google Scholar
• Yang, Z., Q. Zhu, K. Luo, and Q. Zhou. 2001. The 7SK small nuclear RNA inhibits CDK9/cyclin T1 kinase to control transcription. Nature 414: 317–322.
   PubMed Web of Science ®Google Scholar
• Zawel, L., P. Kumar, and D. Reinberg. 1995. Recycling of the general transcription factors during RNA polymerase II transcription. Genes Dev. 9: 1479–1490.
   PubMedGoogle Scholar
• Zhang, J., N. Tamilarasu, S. Hwang, M. E. Garber, I. Huq, K. A. Jones, and T. M. Rana. 2000. HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1. J. Biol. Chem. 275: 34314–34319.
   PubMedGoogle Scholar
• Zhou, M., M. A. Halanski, M. F. Radonovich, F. Kashanchi, J. Peng, D. H. Price, and J. N. Brady. 2000. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 20: 5077–5086.
   PubMed Web of Science ®Google Scholar
• Zhou, M., S. Nekhai, D. C. Bharucha, A. Kumar, H. Ge, D. H. Price, J.-M. Egly, and J. N. Brady. 2001. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription. J. Biol. Chem. 276: 44633–44640.
   PubMed Web of Science ®Google Scholar
• Zhu, Y., T. Pe'ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. B. Mathews, and D. H. Price. 1997. Transcription elongation factor p-TEFb is required for HIV-1 Tat trans-activation in vitro. Genes Dev. 11: 2622–2632.
   PubMed Web of Science ®Google Scholar